UK Pharmaceutical Supplier to Pakistan
Pakistan has a substantial domestic pharmaceutical manufacturing base, but specialty medicines, biologics, oncology products and named patient cases still rely on UK and European imports. The Drug Regulatory Authority of Pakistan (DRAP) controls registration and import permits under the DRAP Act 2012, and Form-6 import permission is required for unregistered medicines. Euro Biom is an MHRA-licensed UK pharmaceutical supplier working with Pakistani tertiary hospitals, oncology centres and private clinics sourcing UK-origin branded, generic, named patient and shortage medicines. We hold WDA wholesale dealer authorisation, stock over 5,800 products, and prepare every export with the documentation DRAP and Pakistan Customs require.
Why Pakistani Hospital Procurement Teams Struggle to Source Reliable UK Pharmaceutical Supply
Pakistan's pharmaceutical import environment is structured around DRAP registration and Form-6 permits. Most UK wholesalers do not understand what DRAP actually checks, and hospital procurement teams pay the price.
DRAP Form-6 Is Specific
For unregistered medicines, Pakistani treating physicians and hospitals apply to DRAP for Form-6 import permission. The application requires a UK supplier with verifiable MHRA credentials and documentation structured to DRAP standards. Most UK wholesalers submit the wrong paperwork and the Form-6 stalls for weeks.
Karachi Customs Rejects Incomplete Paperwork Every Day
Pakistan Customs at Karachi, Lahore and Islamabad airports is strict about Certificate of Pharmaceutical Product, GMP certificates and GDP chain of custody. Consignments with inconsistent or incomplete documentation are held or returned. We see it happen weekly to other UK exporters.
Oncology Centres Need Urgent UK Sourcing
Pakistan's major oncology centres, including those in Karachi and Lahore, frequently need UK-origin targeted therapies and biologics for specific patient cases. The clinical timeline is measured in days, not weeks. Most UK wholesalers are structurally unable to respond that fast.
Cold Chain Integrity to Karachi Summer Conditions
Heathrow to Karachi is a 9 to 10 hour direct flight, and Karachi ramp temperatures in June and July exceed 40 degrees. Biologics, vaccines and gene therapies need validated cold chain containers with planned tarmac mitigation. Most forwarders do not consider this until something goes wrong.
Shortage Response Windows Are Too Short for Most Exporters
When a Pakistani tertiary hospital faces a critical shortage of a specific medicine, they need UK stock confirmation within hours. Most UK wholesalers treat South Asia as a secondary market, send auto-acknowledgements, and respond days later. That is clinically meaningless.
Hospital Pharmacy Teams Need Single Accountability
Pakistani hospital pharmacies cannot run five different wholesaler relationships for one complex import case. They need one UK partner who owns the shipment from Heathrow to Karachi, prepares every certificate, and takes the call when Pakistan Customs asks a clarification question.
An MHRA-Licensed UK Wholesaler Built for Pakistani Hospital Supply
Importing a specialty or named patient medicine into Pakistan should be traceable, DRAP-compliant and fast. Whether you are a consultant at a tertiary hospital in Karachi sourcing a Form-6 medicine, an oncology centre in Lahore managing a specific biologic case, or a private clinic in Islamabad handling an urgent shortage, we handle the UK side so your team can focus on the patient.
We hold MHRA Wholesale Dealer Authorisation WDA(H) 59239, stock over 5,800 medicines across 21 therapeutic areas, and prepare every shipment with DRAP-aligned documentation. Every Certificate of Pharmaceutical Product, batch Certificate of Analysis and GDP record is structured to clear Karachi, Lahore or Islamabad customs on the first attempt.
Based at Heathrow, we dispatch via direct Karachi and Lahore air freight with validated cold chain containers and continuous temperature monitoring. For Form-6 and urgent shortage cases, we respond the same day and dispatch within 24 to 48 hours of DRAP permission being confirmed.
Discuss Your RequirementsWhy Pakistani Hospital Buyers Choose Euro Biom
Practical reasons tertiary hospitals, oncology centres and private clinics across Pakistan work with us for UK-origin medicines.
Publicly Verifiable MHRA Licence
WDA(H) 59239 on the UK MHRA public register. Your DRAP and procurement teams verify us in under a minute. No phantom wholesalers, no unverifiable credentials, no problems at Form-6 supplier review.
DRAP-Aligned Export Documentation
Certificate of Pharmaceutical Product, Certificate of Free Sale, GMP certificates, batch-level Certificate of Analysis and GDP chain of custody, all prepared to the structure DRAP and Pakistan Customs actually check.
Form-6 Named Patient Expertise
We understand what Pakistani treating physicians and hospital pharmacies need on the UK side to support a Form-6 application. Documentation prepared to the correct structure, immediate dispatch once DRAP grants permission.
Oncology and Biologic Sourcing
Active sourcing of UK-origin targeted therapies, monoclonal antibodies and specialty oncology products for Pakistani oncology centres and tertiary hospitals. Traceable GMP provenance with full chain of custody.
We Hold Actual Stock
5,800+ pharmaceutical products in active UK warehouse stock. When we confirm availability for a Pakistani case, the medicine is physically here and ready for dispatch, not a speculative supply chain promise.
Cold Chain to Karachi and Lahore
Validated temperature-controlled containers for biologics, oncology and vaccines. Continuous monitoring Heathrow to destination, with planned tarmac mitigation for Karachi and Lahore summer ramp conditions.
Same-Day Shortage Response
When a Pakistani hospital needs UK-sourced medicine urgently for a shortage or specific patient case, we confirm stock the same day and dispatch within 24 to 48 hours. Clinical timelines, not email-ticket timelines.
One Accountable Point of Contact
Single point of contact from enquiry through to arrival at your hospital pharmacy in Karachi, Lahore or Islamabad. One thread, full visibility, no handoffs when Pakistan Customs calls at 3am.
Pharmaceutical Supply Services for Pakistan
Four service lines built around the real procurement situations Pakistani tertiary hospitals, oncology centres and private clinics face when sourcing UK-origin medicines.
Form-6 Named Patient Supply
For Pakistani treating physicians and hospitals sourcing unregistered medicines under DRAP Form-6 import permission. We provide UK-side sourcing from verified GMP manufacturers, documentation structured for DRAP, and immediate dispatch once Form-6 is granted.
- Form-6 application documentation support
- UK GMP manufacturer sourcing with full provenance
- Oncology, rare disease and specialty products
- Same-day response for urgent cases
Oncology and Specialty Supply
For Pakistani oncology centres in Karachi, Lahore and Islamabad sourcing UK-origin targeted therapies, biologics and specialty oncology medicines. Temperature-validated cold chain, DRAP-aligned documentation, direct dispatch from Heathrow.
- Targeted therapies and monoclonal antibodies
- Validated cold chain to Pakistani hub airports
- DRAP-aligned customs documentation
- Batch-level Certificate of Analysis provided
Shortage and Emergency Medicine Supply
When a Pakistani tertiary hospital faces a critical shortage, we provide UK-sourced alternatives with same-day stock confirmation. Heathrow to Karachi or Lahore on direct air freight with cold chain integrity maintained throughout transit and customs clearance.
- Same-day response for urgent shortage requests
- UK-sourced alternatives with traceable provenance
- Direct Heathrow dispatch, no middlemen
- Full GDP-compliant documentation included
Hospital Procurement Support
For Pakistani private hospital pharmacy teams and procurement managers sourcing UK-origin branded and specialty medicines on a recurring basis. Competitive pricing, consistent delivery timelines, and documentation ready for Pakistan Customs at every shipment.
- Recurring supply agreements
- Private hospital and clinic procurement
- DRAP and customs documentation included
- Consistent delivery timelines
Trusted by Pakistani Hospital Procurement Teams
Procurement managers and treating physicians at tertiary hospitals and oncology centres across Pakistan have chosen Euro Biom for UK-origin medicine supply.
"We needed a biologic for an oncology patient and the clock was tight. Euro Biom confirmed UK stock the same morning, their Form-6 documentation was clean, and the shipment cleared Karachi customs without a single query. That is how it should work."
"Their documentation is prepared exactly how DRAP wants to see it. That has saved us weeks of back-and-forth on several import applications. The MHRA licence check takes thirty seconds and the whole relationship feels like it is built around actually getting medicines to patients."
"For a shortage case they confirmed stock within hours and dispatched the next day. The temperature monitoring log arrived with the shipment and the product was in spec on arrival. We use them now as a first-call partner."
Our Process for Pakistani Pharmaceutical Supply
From first enquiry to arrival at your hospital pharmacy, the process is built to be fast, traceable and DRAP-compliant.
Step 1: Enquiry and UK Stock Check
You send the medicine name, strength, quantity and clinical context. We confirm UK warehouse stock the same day, quote in GBP or USD, and outline the documentation bundle we can provide for DRAP or Form-6.
Step 2: DRAP Documentation Bundle
We prepare Certificate of Pharmaceutical Product, GMP certificate, batch-level Certificate of Analysis, Free Sale Certificate and full GDP chain of custody, structured to DRAP standards for Pakistan Customs clearance.
Step 3: Cold Chain Dispatch from Heathrow
Once payment and import permission are confirmed, we dispatch via direct Karachi or Lahore air freight. Temperature-sensitive products travel in validated containers with continuous monitoring and full chain of custody documentation.
Step 4: Customs Support and Delivery
We remain available throughout Pakistan Customs clearance to respond to any DRAP or customs queries directly. Once cleared, onward delivery to your hospital pharmacy is coordinated with your chosen Pakistani logistics partner.
Pakistan Pharmaceutical Market Insight
Pakistan's large population and expanding hospital infrastructure drive growing demand for imported specialist medicines.
Pakistan's pharmaceutical market, valued at approximately USD 4.5 billion in 2024, serves the world's fifth-largest population of over 230 million people. While Pakistan has a substantial domestic manufacturing sector producing essential medicines, the country relies heavily on imports for advanced biologics, targeted cancer therapies, orphan drugs, and specialty medicines not manufactured locally. The Drug Regulatory Authority of Pakistan (DRAP), established under the DRAP Act 2012, regulates all pharmaceutical imports through a centralised licensing system that replaced the previous provincial regulatory framework.
DRAP operates a structured import pathway for both registered and unregistered medicines. Registered medicines require DRAP marketing authorisation, while unregistered medicines can be imported under the Hardship Case import provision (Section 13 of the DRAP Act) for patients with urgent clinical needs where no locally registered alternative exists. Euro Biom works with Pakistani hospital pharmacies and authorised importers to supply UK-origin medicines through both pathways, providing the MHRA licence documentation, Certificate of Pharmaceutical Product, WHO-type certificates, and batch-level quality records that DRAP requires.
Pakistan's hospital sector is expanding rapidly, with both public and private investment. Major hospitals importing specialist medicines include Aga Khan University Hospital and Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore (one of South Asia's leading oncology centres), Armed Forces Institute of Pathology in Rawalpindi, Shifa International in Islamabad, Indus Hospital Network, and the Sindh Institute of Urology and Transplantation (SIUT) in Karachi. The private hospital sector is growing at approximately 15 percent annually, driving increased demand for imported specialist medicines.
Key therapeutic areas driving UK pharmaceutical imports to Pakistan include oncology (Pakistan has approximately 340,000 new cancer cases annually with limited domestic access to modern targeted therapies), hepatology (Pakistan has one of the world's highest hepatitis C prevalence rates, with approximately 10 million people affected), nephrology and transplant medicine (SIUT performs over 200 kidney transplants annually requiring imported immunosuppressants), and paediatric rare diseases. Pakistan's National Health Vision 2025 and Universal Health Coverage initiatives are gradually expanding access to specialist medicines, which is expected to increase import demand further.
Frequently Asked Questions About UK Medicine Supply to Pakistan
Practical questions from Pakistani hospital pharmacy teams, oncology procurement managers and treating physicians, answered plainly.
Need a UK Pharmaceutical Supplier for Pakistan
Same-day response. MHRA-licensed. DRAP-aligned documentation. Direct dispatch from Heathrow to Karachi, Lahore or Islamabad. Tell us the medicine, the clinical context and the timeline. We will tell you within hours whether we can help.
MHRA WDA(H) 59239 · Company No. 15380737 · Registered England and Wales · work@eurobiom.co.uk